Ask AI
Bill117th CongressFiled Oct 14, 2022Health
H.Res. 1434

Reaffirming the preemptive authority of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.) and the Public Health Service Act (42 U.S.C. 201 et seq.) (including regulations thereunder) with respect to State laws that inhibit access to or use of any reproductive health product.

Bill journey · stage 3 of 5

Passed at least one chamber

Filed
Comm.
Floor
Both
Law

What it doesSummary passed house (Dec 21, 2022)

This resolution affirms that there is well-established authority for the Food and Drug Administration to approve, license, and otherwise regulate reproductive health products under the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act.

The resolution also affirms that (1) such federal laws preempt (i.e., supersede conflicting state or local laws) any state or local laws that prohibit or limit access to or use of any reproductive health product, and (2) the Department of Justice has authority to enforce the preemptive effect of such federal laws by suing any state or political subdivision of a state that prohibits or limits access to or use of any reproductive health product.

What just happenedDec 21, 2022

Pursuant to the provisions of H. Res. 1529, H. Res. 1434 is considered passed House.

Who’s behind it

Rep. Jones, Mondaire [D-NY-17](D-NY)Sponsor
38 cosponsors38 D
Read on Congress.gov
38cosponsors2committees7actions1related bills9subjects
  1. Dec 21, 2022FloorH1B000

    Pursuant to the provisions of H. Res. 1529, H. Res. 1434 is considered passed House.

  2. Dec 21, 2022Floor8000

    Passed/agreed to in House: Pursuant to the provisions of H. Res. 1529, H. Res. 1434 is considered passed House.

  3. Oct 17, 2022Committee

    Referred to the Subcommittee on Health.

    Health Subcommittee
  4. Oct 14, 2022IntroReferralH11100

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Judiciary Committee
  5. Oct 14, 2022IntroReferralH11100

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Energy and Commerce Committee
  6. Oct 14, 2022IntroReferralIntro-H

    Introduced in House

  7. Oct 14, 2022IntroReferral1000

    Introduced in House

Passed HouseDec 21, 202253

This resolution affirms that there is well-established authority for the Food and Drug Administration to approve, license, and otherwise regulate reproductive health products under the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act.

The resolution also affirms that (1) such federal laws preempt (i.e., supersede conflicting state or local laws) any state or local laws that prohibit or limit access to or use of any reproductive health product, and (2) the Department of Justice has authority to enforce the preemptive effect of such federal laws by suing any state or political subdivision of a state that prohibits or limits access to or use of any reproductive health product.

Introduced in HouseOct 14, 2022

This resolution affirms that there is well-established authority for the Food and Drug Administration to approve, license, and otherwise regulate reproductive health products under the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act.

The resolution also affirms that (1) such federal laws preempt (i.e., supersede conflicting state or local laws) any state or local laws that prohibit or limit access to or use of any reproductive health product, and (2) the Department of Justice has authority to enforce the preemptive effect of such federal laws by suing any state or political subdivision of a state that prohibits or limits access to or use of any reproductive health product.

Reaffirming the preemptive authority of the Federal Food, Drug, and Cosmetic Act (21 U.S.C… — Informed